|Age-related alterations in white matter microstructure measured by diffusion tensor imaging|
DH Salat, DS Tuch, DN Greve, AJW Van Der Kouwe, ND Hevelone, ...
Neurobiology of aging 26 (8), 1215-1227, 2005
|Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity|
HD Rosas, DH Salat, SY Lee, AK Zaleta, V Pappu, B Fischl, D Greve, ...
Brain 131 (4), 1057-1068, 2008
|Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures|
HD Rosas, DS Tuch, ND Hevelone, AK Zaleta, M Vangel, SM Hersch, ...
Movement disorders: official journal of the Movement Disorder Society 21 (9 …, 2006
|Regional cortical thinning in preclinical Huntington disease and its relationship to cognition|
HD Rosas, ND Hevelone, AK Zaleta, DN Greve, DH Salat, B Fischl
Neurology 65 (5), 745-747, 2005
|Choice reaction time performance correlates with diffusion anisotropy in white matter pathways supporting visuospatial attention|
DS Tuch, DH Salat, JJ Wisco, AK Zaleta, ND Hevelone, HD Rosas
Proceedings of the national academy of sciences 102 (34), 12212-12217, 2005
|Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2′ dG|
SM Hersch, S Gevorkian, K Marder, C Moskowitz, A Feigin, M Cox, ...
Neurology 66 (2), 250-252, 2006
|White matter pathology isolates the hippocampal formation in Alzheimer's disease|
DH Salat, DS Tuch, AJW Van der Kouwe, DN Greve, V Pappu, SY Lee, ...
Neurobiology of aging 31 (2), 244-256, 2010
|Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical “disconnection”|
HD Rosas, SY Lee, AC Bender, AK Zaleta, M Vangel, P Yu, B Fischl, ...
Neuroimage 49 (4), 2995-3004, 2010
|Complexity and heterogeneity: what drives the ever‐changing brain in Huntington's disease?|
HD Rosas, DH Salat, SY Lee, AK Zaleta, N Hevelone, SM Hersch
Annals of the New York Academy of Sciences 1147 (1), 196-205, 2008
|Patient-centered communication during the disclosure of a dementia diagnosis|
AK Zaleta, BD Carpenter
American Journal of Alzheimer's Disease & Other Dementias® 25 (6), 513-520, 2010
|Pilot randomized controlled trial of a symptom cluster intervention in advanced cancer|
SM Wells‐Di Gregorio, DR Marks, J DeCola, J Peng, D Probst, A Zaleta, ...
Psycho‐oncology 28 (1), 76-84, 2019
|Symptom burden, perceived control, and quality of life among patients living with multiple myeloma|
AK Zaleta, MF Miller, JS Olson, EYN Yuen, TW LeBlanc, CE Cole, ...
Journal of the National Comprehensive Cancer Network 18 (8), 1087-1095, 2020
|Agreement about diagnosis among patients, companions, and professionals following a dementia evaluation|
AK Zaleta, BD Carpenter, EK Porensky, C Xiong, JC Morris
Alzheimer disease and associated disorders 26 (3), 232, 2012
|Perceptions of weight management counseling among gynecologic cancer survivors: opportunities for enhancing survivorship care|
AK Zaleta, R Neff, GA McCann, DM O’Malley, KM Carpenter
Supportive Care in Cancer 25, 1537-1545, 2017
|CancerSupportSource®: validation of a revised multi-dimensional distress screening program for cancer patients and survivors|
JS Buzaglo, AK Zaleta, S McManus, M Golant, MF Miller
Supportive Care in Cancer 28 (1), 55-64, 2020
|Unintentional weight loss, its associated burden, and perceived weight status in people with cancer|
EYN Yuen, AK Zaleta, S McManus, JS Buzaglo, TW LeBlanc, K Hamilton, ...
Supportive Care in Cancer 28, 329-339, 2020
|Perspectives of patients with cancer on the quality-adjusted life year as a measure of value in healthcare|
EF Franklin, HM Nichols, E Charap, JS Buzaglo, AK Zaleta, L House
Value in Health 22 (4), 474-481, 2019
|Access to care in cancer: barriers and challenges.|
MB Gonzalo, L House, K Santiago, JS Buzaglo, AK Zaleta, NK Gupta
Journal of Clinical Oncology 35 (8_suppl), 33-33, 2017
|Care and Treatment Decisions in Cancer: The Role of the Family Caregiver.|
ML Longacre, MF Miller, M Golant, AK Zaleta, JS Buzaglo
Journal of Oncology Navigation & Survivorship 9 (9), 2018
|Symptom burden, palliative care needs, and patient-provider communication among chronic myeloid leukemia survivors|
AK Zaleta, MF Miller, J Johnson, S McManus, C Karten, MJ Mauro, ...
Blood 130, 4704, 2017